ArticleBMJ open2023

Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol.

Zerui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.